:quality(70))
Humaneva, the healthcare group behind Pratia, brings together perspectives from across clinical research and drug development. Humaneva Insights explores the ideas, decisions, and developments shaping the industry.
Through candid conversations with researchers, industry leaders, and innovators, it explores emerging ideas, tackle real-world challenges, and connect scientific progress with the people and practices that bring it to life.
In the new episode host Patrick McManus speaks with Scott E. Smith, MD, PhD, FACP, Chief Medical Officer at Kapadi, about the emerging role of PD-1/VEGF bispecific antibodies in cancer treatment.
The conversation explores the science behind this approach and what emerging clinical data could mean for the future of immuno-oncology. It also considers the implications for drug developers, from choosing trial comparators to deciding how new therapies fit into existing treatment approaches.